Ocular Therapeutix (OCUL) Asset Utilization Ratio (2014 - 2026)

Ocular Therapeutix's Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.07 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 51.08% year-over-year to 0.07 in Q1 2026; TTM through Mar 2026 was 0.07, a 51.08% decrease from a year earlier, with the FY2025 full-year figure at 0.08, down 54.28% from the prior year.
• Asset Utilization Ratio fell to 0.07 in Q1 2026 per OCUL's latest filing, from 0.09 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.43 in Q2 2023 and bottomed at 0.07 in Q1 2026.
• The 5-year median for Asset Utilization Ratio is 0.15 (2024), against an average of 0.22.
• Across the five-year window, Asset Utilization Ratio soared 186.87% in 2022 and plunged 73.39% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.33 in 2022, then dropped by 15.69% to 0.28 in 2023, then plunged by 52.35% to 0.13 in 2024, then slumped by 36.57% to 0.09 in 2025, then slipped by 20.75% to 0.07 in 2026.
• Per Business Quant, the three latest OCUL Asset Utilization Ratio figures stand at 0.07 (Q1 2026), 0.09 (Q4 2025), and 0.13 (Q3 2025).